Is Immunome, Inc. overvalued?

Immunome, Inc. (IMNM) — key valuation metrics and fundamentals.

No verdict

Price

$26.41

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.52B

Dividend yield

0.0%

Return on equity

-51.2%

Sector

Healthcare

Fair value compares IMNM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks